CH660125A5 - Gereinigtes, entgiftetes endotoxin enthaltende zusammensetzung. - Google Patents

Gereinigtes, entgiftetes endotoxin enthaltende zusammensetzung. Download PDF

Info

Publication number
CH660125A5
CH660125A5 CH4001/84A CH400184A CH660125A5 CH 660125 A5 CH660125 A5 CH 660125A5 CH 4001/84 A CH4001/84 A CH 4001/84A CH 400184 A CH400184 A CH 400184A CH 660125 A5 CH660125 A5 CH 660125A5
Authority
CH
Switzerland
Prior art keywords
endotoxin
purified
detoxified
composition
detoxified endotoxin
Prior art date
Application number
CH4001/84A
Other languages
German (de)
English (en)
Inventor
Edgar Ernst Ribi
Original Assignee
Ribi Immunochem Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribi Immunochem Research Inc filed Critical Ribi Immunochem Research Inc
Publication of CH660125A5 publication Critical patent/CH660125A5/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/05—Immunological preparations stimulating the reticulo-endothelial system, e.g. against cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55544—Bacterial toxins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Dispersion Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH4001/84A 1983-08-26 1984-08-21 Gereinigtes, entgiftetes endotoxin enthaltende zusammensetzung. CH660125A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52696783A 1983-08-26 1983-08-26

Publications (1)

Publication Number Publication Date
CH660125A5 true CH660125A5 (de) 1987-03-31

Family

ID=24099553

Family Applications (1)

Application Number Title Priority Date Filing Date
CH4001/84A CH660125A5 (de) 1983-08-26 1984-08-21 Gereinigtes, entgiftetes endotoxin enthaltende zusammensetzung.

Country Status (22)

Country Link
JP (1) JPS6072825A (enrdf_load_stackoverflow)
KR (1) KR880002223B1 (enrdf_load_stackoverflow)
AT (1) AT389228B (enrdf_load_stackoverflow)
AU (1) AU554039B2 (enrdf_load_stackoverflow)
BE (1) BE900377A (enrdf_load_stackoverflow)
CA (1) CA1225592A (enrdf_load_stackoverflow)
CH (1) CH660125A5 (enrdf_load_stackoverflow)
DE (2) DE3448164C2 (enrdf_load_stackoverflow)
DK (1) DK389384A (enrdf_load_stackoverflow)
ES (1) ES8606883A1 (enrdf_load_stackoverflow)
FI (1) FI843204L (enrdf_load_stackoverflow)
FR (1) FR2550945B1 (enrdf_load_stackoverflow)
GB (1) GB2147806B (enrdf_load_stackoverflow)
HU (1) HU191713B (enrdf_load_stackoverflow)
IL (1) IL72675A (enrdf_load_stackoverflow)
IN (1) IN157910B (enrdf_load_stackoverflow)
IT (1) IT1177974B (enrdf_load_stackoverflow)
NL (1) NL192326C (enrdf_load_stackoverflow)
NO (1) NO843243L (enrdf_load_stackoverflow)
NZ (1) NZ209233A (enrdf_load_stackoverflow)
SE (1) SE8404090L (enrdf_load_stackoverflow)
ZA (1) ZA846309B (enrdf_load_stackoverflow)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4629722A (en) * 1984-07-12 1986-12-16 Ribi Immunochem Research, Inc. Method of inhibiting the onset of acute radiation syndrome
US4803070A (en) * 1986-04-15 1989-02-07 Ribi Immunochem Research Inc. Immunological emulsion adjuvants for polysaccharide vaccines
US4806352A (en) * 1986-04-15 1989-02-21 Ribi Immunochem Research Inc. Immunological lipid emulsion adjuvant
DE10115310A1 (de) * 2001-03-28 2002-10-10 Nodar A Daniela Bakteriophagen-Präparation
KR100868443B1 (ko) * 2002-05-27 2008-11-11 주식회사 포스코 폭과 길이가 가변 조정되는 런치박스 제작장치

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2160326B1 (enrdf_load_stackoverflow) * 1971-11-19 1975-02-07 Anvar
BE793260A (fr) * 1971-12-24 1973-06-22 Pasteur Institut Agent immunostimulant, medicaments le contenant et procede de fabrication de cet agent immunostimulant
FR2275224A1 (fr) * 1974-06-20 1976-01-16 Anvar Fractions mycobacteriennes utilisables comme agent anti-infectieux, et procede pour leur preparation
FR2393065A1 (fr) * 1977-05-31 1978-12-29 Merieux Inst Procede de separation de lipides d'endotoxines bacteriennes et notamment d'endotoxine de bordetella pertussis
US4436728A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4435386A (en) * 1982-05-26 1984-03-06 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436727A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product

Also Published As

Publication number Publication date
JPS6072825A (ja) 1985-04-24
IT8448757A1 (it) 1986-02-24
AU554039B2 (en) 1986-08-07
DK389384A (da) 1985-02-27
ES535124A0 (es) 1986-05-01
BE900377A (fr) 1985-02-18
SE8404090D0 (sv) 1984-08-14
KR880002223B1 (ko) 1988-10-20
IL72675A0 (en) 1984-11-30
NL192326B (nl) 1997-02-03
NL192326C (nl) 1997-06-04
ATA273384A (de) 1989-04-15
DE3448164C2 (enrdf_load_stackoverflow) 1987-06-25
DK389384D0 (da) 1984-08-13
GB2147806A (en) 1985-05-22
GB2147806B (en) 1986-10-22
HU191713B (en) 1987-03-30
IT1177974B (it) 1987-09-03
KR850001696A (ko) 1985-04-01
JPH0556326B2 (enrdf_load_stackoverflow) 1993-08-19
DE3431058A1 (de) 1985-03-07
FI843204A7 (fi) 1985-02-27
IT8448757A0 (it) 1984-08-24
FR2550945A1 (fr) 1985-03-01
NZ209233A (en) 1987-11-27
ES8606883A1 (es) 1986-05-01
NL8402515A (nl) 1985-03-18
AU3221584A (en) 1985-02-28
CA1225592A (en) 1987-08-18
FR2550945B1 (fr) 1988-09-16
NO843243L (no) 1985-02-27
DE3431058C2 (enrdf_load_stackoverflow) 1987-06-11
GB8420612D0 (en) 1984-09-19
FI843204A0 (fi) 1984-08-14
SE8404090L (sv) 1985-02-27
IN157910B (enrdf_load_stackoverflow) 1986-07-19
ZA846309B (en) 1985-03-27
HUT34887A (en) 1985-05-28
FI843204L (fi) 1985-02-27
IL72675A (en) 1988-04-29
AT389228B (de) 1989-11-10

Similar Documents

Publication Publication Date Title
DE2954387C2 (de) Die tumorspezifische Immunität vergrößernder Bakterienzellenextrakt und Verfahren zu seiner Herstellung
DE69826842T2 (de) Wässerige immunologische adjuvantzusammensetzungen aus monophosphoryllipid a
DE3921416C2 (de) Modifizierte Lipopolysaccharide, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzung
DE3318567C2 (de) Therapeutisches Mittel, enthaltend gereinigtes, entgiftetes Endotoxin, Zellwandgerüst und Trehalosedimycolat
DE69937343T2 (de) Adjuvanszusammensetzung und methoden zu deren verwendung
DE60037514T2 (de) Wässrige immunologische adjuvantzusammensetzungen aus monophosphoryllipid a
DE3318568C2 (de) Therapeutische Zusammensetzung zur Bekämpfung von Tumoren enthaltend gereinigtes, entgiftetes Endotoxin, Trehalosedimycolat und ein mit Azeton ausgefälltes Nebenprodukt von mit Chloroform-Methanol extrahierten endotoxischen Glykolipiden
DE3318569A1 (de) Verfahren zur herstellung von gereinigtem, entgiftetem endotoxin
DE2725204C2 (de) Verfahren zum Herstellen eines die unspezifische Immunität stimulierenden löslichen Mikroorganismenextrakts und diesem enthaltendes Arzneimittel
CH678492A5 (enrdf_load_stackoverflow)
DE3407823C2 (enrdf_load_stackoverflow)
DE3434766A1 (de) Einen pyridinloeslichen extrakt und gereinigtes entgiftetes endotoxin enthaltendes pharmazeutisches praeparat
EP0363835B1 (de) Verwendung von Zink- oder Eisenhydroxid zur Adjuvierung von Antigenlösungen und auf diese Weise adjuvierte Antigenlösungen
DE19511276C2 (de) Adjuvans auf der Basis kolloidaler Eisenverbindungen
DE2519938A1 (de) Extrakte von corynebakterien, verfahren zu ihrer herstellung und ihre verwendung in arzneimittelzubereitungen
DE2547105A1 (de) N-acetyl-muramyl-l-alanyl-d-isoglutamin enthaltende oelfreie adjuvanzien
CH641354A5 (de) Material mit antitumorwirkung und verfahren zu dessen herstellung.
DE2355094A1 (de) Tetanus-vaccine und verfahren zu deren herstellung
CH660125A5 (de) Gereinigtes, entgiftetes endotoxin enthaltende zusammensetzung.
DE1924304C3 (de) Diäthylaminoäthyldextran (DEAE-D) als Adjuvans für Impfstoffe zur aktiven Immunisierung von Säugetieren
DE2262427C3 (de) Immunostimulierendes Mittel
DE69810024T2 (de) Inhibitor der immunoglobulin e antikörpererzeugung zur behandlung von typ i allergie-verwandten krankheiten
CH630807A5 (de) Verfahren zur herstellung eines antiserums.
EP0445710A1 (de) Verwendung von Zink-Calciumhydroxid, Lecithin und PAO zur Adjuvierung von Antigenlösungen und auf diese Weise adjuvierte Antigenlösungen
DE3323093C2 (de) Pharmazeutisches Präparat zur Bekämpfung von Tumoren

Legal Events

Date Code Title Description
PL Patent ceased